<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00368563</url>
  </required_header>
  <id_info>
    <org_study_id>PEN.1010.02</org_study_id>
    <nct_id>NCT00368563</nct_id>
  </id_info>
  <brief_title>A Capacitance and Transepidermal Water Loss Test to Determine the Ability of Sunscreen to Moisturize Skin</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loreal USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loreal USA</source>
  <brief_summary>
    <textblock>
      To evaluate the ability of 2 Helioblock SX Cream formulations to moisturize skin using
      capacitance and transepidermal water loss methodology
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">October 2006</completion_date>
  <primary_completion_date type="Actual">October 2006</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <condition>Dry Skin</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Helioblock SX</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy,male or female subjects 18 years to 55 years of age, with a minimum Stanfield
             score at baseline of &quot;2&quot; at the forearm sites intended to be assessed in the study

          -  Female subjects of childbearing potential using a reliable form of contraception
             during the course of the study(oral contraceptive pill, intrauterine device, bilateral
             tubal ligation, abstinence, or other reliable forms at the discretion of the
             Investigator.) or of non childbearing potential(i.e.,post-menopausal(one year without
             menstrual period), hysterectomy or bilateral ovariectomy)

          -  Subjects who have read, understood and signed an informed consent

          -  Subjects who are willing and capable of cooperating to the extent and degree required
             by the protocol

          -  Absence of any visible skin diseases which might be confused with a skin reaction from
             the test material

        Exclusion Criteria:

          -  Subjects with a condition, or in a situation, which in the Investigator's or
             Sub-Investigator's opinion, may suggest a significant hazard for the subject, may
             confound the study results, or may interfere with the subject's participation in the
             study.

          -  Subjects with known sensitivities to any of the study preparations or to other skin
             care products

          -  Subjects who have participated in a clinical research study, including consumer
             products studies, within the last 30 days prior to enrollment

          -  Subjects who are currently receiving medication(prescription or OTC) that in the
             opinion of the Investigator may interfere with the evaluations made in this study
             (e.g.vasoactive substances)

          -  Pregnant or nursing females or women who are planning to get pregnant during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Linda Oddo, B.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hill Top Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hill Top Research</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85251</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2006</study_first_submitted>
  <study_first_submitted_qc>August 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2006</study_first_posted>
  <last_update_submitted>February 10, 2009</last_update_submitted>
  <last_update_submitted_qc>February 10, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2009</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

